Drug Approval | August 01, 2024
Shilpa Pharma Lifesciences received CEP from EDQM for ursodeoxycholic acid
Ursodeoxycholic acid or ursodiol is a naturally occurring bile acid that is used dissolve cholesterol gall stones
Ursodeoxycholic acid or ursodiol is a naturally occurring bile acid that is used dissolve cholesterol gall stones
Dyslipidemia is a critical risk factor for cardiovascular diseases
The initiative aims to empower individuals to take proactive steps towards monitoring their health
Commercialization of rPEG lipids designed to improve immunogenicity profile for nucleic acid delivery
Pitavastatin Tablets are indicated as an adjunct to diet to reduce low-density lipoprotein cholesterol
PhytoSquene now available for clinical and commercial use
Aim is to treat Dyslipidemia by inhibiting PCSK9 with a novel entity
This study showed that patients taking 75mg of Olpasiran previously every 12 weeks presented a 40–50% reduction in LP(a)
Lilly to further investigate retatrutide for the treatment of obesity in the TRIUMPH phase 3 clinical program
The disease is caused by a mutation in the gene encoding HMG CoA reductase, inhibiting the enzyme’s activity.
Subscribe To Our Newsletter & Stay Updated
